Visgeneer Inc. (TPEX:4197)
7.10
-0.32 (-4.31%)
Nov 20, 2026, 1:11 PM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 214.28 million as of November 20, 2026. It is the 43,393rd most valuable company in the world and the 2,350th biggest in Taiwan. Its market cap has decreased by 30.39% in one year.
Market Cap
214.28M
Enterprise Value
271.28M
Revenue
170.72M
Global Rank
Country Rank
#2,350 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 214.28M, a decrease of -76.15%. That is a compound annual growth rate of -10.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 215.79M | -26.29% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 693.67M |
| Meribank Biotech | 671.83M |
| NatureWise Biotech & Medicals | 656.59M |
| Neith | 635.22M |
| SynCore Biotechnology Co.,Ltd | 553.85M |
| Taiwan Advance Bio-Pharmaceutical | 540.00M |
| Vectorite Biomedical | 457.41M |
| TaiwanJ Pharmaceuticals | 428.65M |